Covered recipient · General Payments record
JASON SINGH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$528.46
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $480.86 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $385.13 | 14 |
| PFIZER INC. | $43.82 | 2 |
| Astellas Pharma US Inc | $22.60 | 1 |
| Acerta Pharma LLC | $15.34 | 1 |
| Currax Pharmaceuticals LLC | $13.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $22.60 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139428528 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.34 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104311886 | CMS |
| Currax Pharmaceuticals LLC | $13.97 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089511540 | CMS |
| Novo Nordisk Inc | $24.55 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096907227 | CMS |
| Novo Nordisk Inc | $23.37 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097825610 | CMS |
| Novo Nordisk Inc | $9.99 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097571924 | CMS |
| Novo Nordisk Inc | $17.82 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096631390 | CMS |
| Novo Nordisk Inc | $20.58 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096669399 | CMS |
| Novo Nordisk Inc | $21.44 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096882040 | CMS |
| Novo Nordisk Inc | $19.48 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097357883 | CMS |
| Novo Nordisk Inc | $11.62 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097753286 | CMS |
| Novo Nordisk Inc | $20.20 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097289902 | CMS |
| Novo Nordisk Inc | $21.36 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097434072 | CMS |
| Novo Nordisk Inc | $21.00 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097157781 | CMS |
| Novo Nordisk Inc | $124.99 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096999355 | CMS |
| Novo Nordisk Inc | $17.76 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097397120 | CMS |
| Novo Nordisk Inc | $30.97 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097460752 | CMS |
| PFIZER INC. | $22.70 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131386856 | CMS |
| PFIZER INC. | $21.12 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132120718 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.